Yahoo
Frankfurt - Delayed Quote EUR

Vext Science, Inc. (VV5.F)

0.1380 -0.0030 (-2.13%)
As of 8:01:02 AM GMT+1. Market Open.
Chart Range Bar
Loading chart for VV5.F
  • Previous Close 0.1410
  • Open 0.1380
  • Bid 0.1380 x --
  • Ask 0.1570 x --
  • Day's Range 0.1380 - 0.1380
  • 52 Week Range 0.0645 - 0.2100
  • Volume 1,900
  • Avg. Volume 29
  • Market Cap (intraday) 34.184M
  • Beta (5Y Monthly) 0.89
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0500
  • Earnings Date (est.) Nov 19, 2026
  • Forward Dividend & Yield -- (0.00%)
  • Ex-Dividend Date --
  • 1y Target Est --

Vext Science, Inc., through its subsidiaries, engages in integrated cannabis operations in the United States. It owns and manages cultivation facilities, manufacturing units, and dispensaries; and involves in the cultivation, extraction, manufacture, and sale of THC and CBD cartridges, concentrates, edibles, and extracts. The company also engages in the retail dispensary activities; and wholesale distribution of cannabis THC and hemp CBD products under the Vapen, Pure Touch, Appalachian Pharm, Herbal Wellness, Prism, Firebrand, and Revibe brands. The company was formerly known as Vapen MJ Ventures Corporation and changed its name to Vext Science, Inc. in November 2019. Vext Science, Inc. was incorporated in 2015 and is headquartered in Phoenix, Arizona.

vextscience.com

--

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Performance Overview

Trailing total returns as of 10/29/2026, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .

YTD Return

VV5.F
12.10%
S&P/TSX Composite index (^GSPTSE)
13.80%

1-Year Return

VV5.F
13.75%
S&P/TSX Composite index (^GSPTSE)
20.30%

3-Year Return

VV5.F
23.76%
S&P/TSX Composite index (^GSPTSE)
93.54%

5-Year Return

VV5.F
73.46%
S&P/TSX Composite index (^GSPTSE)
72.39%

Earnings Trends

View More

Earnings Per Share

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q2 FY26
Revenue 12.12M
Earnings -315k
Profit Margin -2.60%

Q3

FY25

Q4

FY25

Q1

FY26

Q2

FY26

-10M
-5M
0
5M
10M
-60.0%
-40.0%
-20.0%
0.0%

Statistics

View More

Valuation Measures

Annual
As of 10/26/2026
  • Market Cap

    36.24M

  • Enterprise Value

    61.84M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (current)

    --

  • Price/Sales (ttm)

    0.86

  • Price/Book (mrq)

    0.78

  • Enterprise Value/Revenue

    1.42

  • Enterprise Value/EBITDA

    9.35

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -28.39%

  • Return on Assets (ttm)

    -1.82%

  • Return on Equity (ttm)

    -22.98%

  • Revenue (ttm)

    50.68M

  • Net Income Avi to Common (ttm)

    -14.39M

  • Diluted EPS (ttm)

    -0.0500

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    4.54M

  • Total Debt/Equity (mrq)

    62.33%

  • Levered Free Cash Flow (ttm)

    1.94M

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: